These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20981524)

  • 1. Structure-based library design in efficient discovery of novel inhibitors.
    Yan S; Selliah R
    Methods Mol Biol; 2011; 685():175-90. PubMed ID: 20981524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening.
    Kim ND; Chun H; Park SJ; Yang JW; Kim JW; Ahn SK
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3329-34. PubMed ID: 21531135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors.
    Stammers TA; Coulombe R; Rancourt J; Thavonekham B; Fazal G; Goulet S; Jakalian A; Wernic D; Tsantrizos Y; Poupart MA; Bös M; McKercher G; Thauvette L; Kukolj G; Beaulieu PL
    Bioorg Med Chem Lett; 2013 May; 23(9):2585-9. PubMed ID: 23545108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase.
    Ding Y; Smith KL; Varaprasad CV; Chang E; Alexander J; Yao N
    Bioorg Med Chem Lett; 2007 Feb; 17(3):841-5. PubMed ID: 16990004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.
    Yan S; Larson G; Wu JZ; Appleby T; Ding Y; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):63-7. PubMed ID: 17049849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors.
    Ivanenkov YA; Veselov MS; Shakhbazyan AG; Aladinskiy VA; Aladinskaya AV; Yartseva SM; Majouga AG; Vantskul AS; Leonov SV; Ivachtchenko AV; Koteliansky VE
    Curr Top Med Chem; 2016; 16(12):1372-82. PubMed ID: 26585933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Development of Metal-Catalyzed Coupling Reactions in the Synthesis of Dasabuvir, an HCV-Polymerase Inhibitor.
    Barnes DM; Shekhar S; Dunn TB; Barkalow JH; Chan VS; Franczyk TS; Haight AR; Hengeveld JE; Kolaczkowski L; Kotecki BJ; Liang G; Marek JC; McLaughlin MA; Montavon DK; Napier JJ
    J Org Chem; 2019 Apr; 84(8):4873-4892. PubMed ID: 30629443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
    Lim SK; Othman R; Yusof R; Heh CH
    Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
    J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Approaches to the Design of NS5A Inhibitors.
    Ivanenkov YA; Veselov MS; Aladinskiy VA; Shakhbazyan AG; Yartseva SM; Majouga AG; Aladinskaya AV; Vantskul AS; Leonov SV; Ivachtchenko AV; Koteliansky VE
    Curr Top Med Chem; 2016; 16(12):1383-91. PubMed ID: 26585932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.
    Faucher AM; Bailey MD; Beaulieu PL; Brochu C; Duceppe JS; Ferland JM; Ghiro E; Gorys V; Halmos T; Kawai SH; Poirier M; Simoneau B; Tsantrizos YS; Llinàs-Brunet M
    Org Lett; 2004 Aug; 6(17):2901-4. PubMed ID: 15330643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5888-91. PubMed ID: 16934455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolones as HCV NS5B polymerase inhibitors.
    Kumar DV; Rai R; Brameld KA; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Shaghafi MB; Hu H; Lehoux I; To N; Young WB; Green MJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):82-7. PubMed ID: 21145235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication.
    Barreca ML; Manfroni G; Leyssen P; Winquist J; Kaushik-Basu N; Paeshuyse J; Krishnan R; Iraci N; Sabatini S; Tabarrini O; Basu A; Danielson UH; Neyts J; Cecchetti V
    J Med Chem; 2013 Mar; 56(6):2270-82. PubMed ID: 23409936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
    Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.